,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,47891,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,9822,NAD-dependent protein deacylase sirtuin-6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9822,Q8N6T7,NAD-dependent protein deacetylase sirtuin-6,51548,SIRT6,9606,Homo sapiens (human),,IC50 (nM),189400.0,PMID:28222243|DOI:10.1002/cbic.201600655,https://www.ncbi.nlm.nih.gov/pubmed/28222243|https://doi.org/10.1002/cbic.201600655,28222243,10.1002/cbic.201600655,
1,52867,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,HCAR2,https://www.dgidb.org/genes/hgnc:24827,,,338442,HCAR2,9606,Homo sapiens (human),,,,,,,,
2,54342,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,DGAT2,https://www.dgidb.org/genes/hgnc:16940,,,84649,DGAT2,9606,Homo sapiens (human),,,,,,,,
3,70129,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,SIRT3,https://www.dgidb.org/genes/hgnc:14931,,,23410,SIRT3,9606,Homo sapiens (human),,,,,,,,
4,75478,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,
5,75479,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001241,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,https://www.drugbank.ca/bio_entities/BE0001241,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,683,BST1,9606,Homo sapiens (human),Product of,,,PMID:16690024|PMID:9378973,https://www.ncbi.nlm.nih.gov/pubmed/16690024|https://www.ncbi.nlm.nih.gov/pubmed/9378973,16690024|9378973,,
6,75480,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001869,Exotoxin A,https://www.drugbank.ca/bio_entities/BE0001869,P11439,Exotoxin A,877850,toxA,208964,Pseudomonas aeruginosa PAO1,Product of,,,PMID:14705944|PMID:8692916|PMID:6419320,https://www.ncbi.nlm.nih.gov/pubmed/14705944|https://www.ncbi.nlm.nih.gov/pubmed/8692916|https://www.ncbi.nlm.nih.gov/pubmed/6419320,14705944|8692916|6419320,,
7,75672,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",https://www.drugbank.ca/bio_entities/BE0003362,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23408,SIRT5,9606,Homo sapiens (human),,,,PMID:10592235|PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,10592235|17139284|17016423,,
8,75673,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0000425,L-lactate dehydrogenase A chain,https://www.drugbank.ca/bio_entities/BE0000425,P00338,L-lactate dehydrogenase A chain,3939,LDHA,9606,Homo sapiens (human),,,,PMID:10592235|PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,10592235|17139284|17016423,,
9,75674,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/11752352,11752352,,
10,75675,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565,CYP2D6,9606,Homo sapiens (human),Inhibitor,,,PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15081432,15081432,,
11,75676,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571,CYP2E1,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:15081432|PMID:23418369,https://www.ncbi.nlm.nih.gov/pubmed/15081432|https://www.ncbi.nlm.nih.gov/pubmed/23418369,15081432|23418369,,
12,75677,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576,CYP3A4,9606,Homo sapiens (human),Inhibitor,,,PMID:15762770|PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15762770|https://www.ncbi.nlm.nih.gov/pubmed/15081432,15762770|15081432,,
13,80079,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0002461,NAD-dependent protein deacetylase sirtuin-1,http://www.t3db.ca/biodb/bio_entities/BE0002461,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,23411,SIRT1,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324|PMID:23318905|PMID:19734050|PMID:16697640,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324|https://www.ncbi.nlm.nih.gov/pubmed/23318905|https://www.ncbi.nlm.nih.gov/pubmed/19734050|https://www.ncbi.nlm.nih.gov/pubmed/16697640,25041433|22419041|17145705|19700324|23318905|19734050|16697640,,
14,80275,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005534,NAD-dependent protein deacetylase sirtuin-2,http://www.t3db.ca/biodb/bio_entities/BE0005534,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,22933,SIRT2,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324|PMID:17149860|PMID:18269226|PMID:15566299,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324|https://www.ncbi.nlm.nih.gov/pubmed/17149860|https://www.ncbi.nlm.nih.gov/pubmed/18269226|https://www.ncbi.nlm.nih.gov/pubmed/15566299,25041433|22419041|17145705|19700324|17149860|18269226|15566299,,
15,80276,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:25041433|PMID:22419041|PMID:18809672|PMID:12825952|PMID:20364863|PMID:23481647,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://www.ncbi.nlm.nih.gov/pubmed/12825952|https://www.ncbi.nlm.nih.gov/pubmed/20364863|https://www.ncbi.nlm.nih.gov/pubmed/23481647,11752352|25041433|22419041|18809672|12825952|20364863|23481647,,
16,80277,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003362,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23408,SIRT5,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235|PMID:25041433|PMID:22419041|PMID:17145705,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705,17139284|17016423|10592235|25041433|22419041|17145705,,
17,80278,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0000425,L-lactate dehydrogenase A chain,http://www.t3db.ca/biodb/bio_entities/BE0000425,P00338,L-lactate dehydrogenase A chain,3939,LDHA,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235|PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,17139284|17016423|10592235|25041433|22419041,,
18,80279,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0001241,ADP-ribosyl cyclase 2,http://www.t3db.ca/biodb/bio_entities/BE0001241,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,683,BST1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,17139284|17016423|25041433|22419041,,
19,80280,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0004547,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004547,Q9NTG7,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",23410,SIRT3,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324,25041433|22419041|17145705|19700324,,
20,80281,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005578,Klotho,http://www.t3db.ca/biodb/bio_entities/BE0005578,Q9UEF7,Klotho,9365,KL,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
21,80282,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005579,NADPH oxidase 4,http://www.t3db.ca/biodb/bio_entities/BE0005579,Q9NPH5,NADPH oxidase 4,50507,NOX4,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
22,80474,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0003645,Solute carrier family 22 member 8,http://www.t3db.ca/biodb/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376,SLC22A8,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
23,80475,936,Therapeutic Target Database (TTD),Niacinamide,D06NVJ,Nicotinamide,https://idrblab.net/ttd/data/drug/details/D06NVJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,,,,,
24,96353,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,SIRT1,https://www.dgidb.org/genes/hgnc:14929,,,23411,SIRT1,9606,Homo sapiens (human),,,,,,,,
25,111604,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of ACACA protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
26,111605,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),Niacinamide results in decreased phosphorylation of ACACA protein,,,PMID:19071085,https://www.ncbi.nlm.nih.gov/pubmed/19071085,19071085,,
27,111606,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of ACACA mrna],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
28,111607,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636,ACE,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in increased expression of ACE mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of ACE mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of ACE mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
29,111808,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272,ACE2,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
30,111809,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370,ADIPOQ,10090,Mus musculus (house mouse),Niacinamide results in increased secretion of ADIPOQ protein,,,PMID:17452443,https://www.ncbi.nlm.nih.gov/pubmed/17452443,17452443,,
31,111810,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370,ADIPOQ,10116,Rattus norvegicus (Norway rat),[alloxan co-treated with niacinamide] affects the expression of ADIPOQ protein,,,PMID:26429928,https://www.ncbi.nlm.nih.gov/pubmed/26429928,26429928,,
32,111811,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370,ADIPOQ,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of ADIPOQ protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ADIPOQ protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
33,111812,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,27161,AGO2,https://ctdbase.org/detail.go?type=gene&acc=27161,,,27161,AGO2,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of AGO2 mrna]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
34,111813,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185,AGTR1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in decreased expression of AGTR1 mrna]|[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of AGTR1 mRNA,,,PMID:18420994,https://www.ncbi.nlm.nih.gov/pubmed/18420994,18420994,,
35,111814,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Coumarin inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/21630391,21630391,,
36,111815,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:22056647,https://www.ncbi.nlm.nih.gov/pubmed/22056647,22056647,,
37,111816,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of CAT protein]|[streptozocin co-treated with niacinamide] results in decreased expression of CAT protein|eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of CAT protein],,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
38,112014,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein]|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
39,112015,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
40,112016,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein,,,PMID:20307516|PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/20307516|https://www.ncbi.nlm.nih.gov/pubmed/21630391,20307516|21630391,,
41,112017,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Pioglitazone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]|saponins inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:29247773,https://www.ncbi.nlm.nih.gov/pubmed/29247773,29247773,,
42,112018,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21439372|PMID:23677724,https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/23677724,21439372|23677724,,
43,112019,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein,,,PMID:21382363|PMID:21439372|PMID:22056647|PMID:23677724|PMID:29247773,https://www.ncbi.nlm.nih.gov/pubmed/21382363|https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/22056647|https://www.ncbi.nlm.nih.gov/pubmed/23677724|https://www.ncbi.nlm.nih.gov/pubmed/29247773,21382363|21439372|22056647|23677724|29247773,,
44,112020,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21382363,https://www.ncbi.nlm.nih.gov/pubmed/21382363,21382363,,
45,112021,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347,CCL2,9606,Homo sapiens (human),Niacinamide results in decreased expression of CCL2 protein,,,PMID:14627904,https://www.ncbi.nlm.nih.gov/pubmed/14627904,14627904,,
46,112022,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364,CCL20,9606,Homo sapiens (human),Niacinamide results in increased expression of CCL20 mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
47,112216,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,952,CD38,https://ctdbase.org/detail.go?type=gene&acc=952,,,952,CD38,10090,Mus musculus (house mouse),CD38 gene mutant form promotes the reaction [niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]],,,PMID:20200208,https://www.ncbi.nlm.nih.gov/pubmed/20200208,20200208,,
48,112217,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958,CD40,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased expression of CD40 mrna],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
49,112218,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Niacinamide results in decreased expression of CDKN1A protein|niacinamide inhibits the reaction [tert-butylhydroperoxide results in increased expression of CDKN1A protein],,,PMID:12782109,https://www.ncbi.nlm.nih.gov/pubmed/12782109,12782109,,
50,112219,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mrna]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
51,112220,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10116,Rattus norvegicus (Norway rat),Niacinamide results in increased expression of CDKN1A protein|niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of CDKN1A protein]],,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
52,112221,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027,CDKN1B,10116,Rattus norvegicus (Norway rat),Niacinamide results in increased expression of CDKN1B protein|niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of CDKN1B protein]],,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
53,112222,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029,CDKN2A,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
54,112223,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of COL1A1 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
55,112224,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278,COL1A2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
56,112444,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4512,COX1,https://ctdbase.org/detail.go?type=gene&acc=4512,,,4512,COX1,9606,Homo sapiens (human),Niacinamide results in increased expression of COX1 protein|niacinamide results in increased expression of COX1 mRNA,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
57,112445,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),"[niacinamide co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA",,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
58,112446,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of CXCL8 mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
59,112447,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Niacinamide results in increased expression of CXCL8 mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
60,112448,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CXCL8 mrna]",,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
61,112449,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535,CYBA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [niacinamide results in increased expression of CYBA mrna]|clofibrate inhibits the reaction [niacinamide results in increased expression of CYBA mrna]|niacinamide results in increased expression of CYBA mrna|gw 6471 inhibits the reaction [resveratrol inhibits the reaction [niacinamide results in increased expression of CYBA mrna]],,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
62,112450,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586,CYP17A1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased expression of CYP17A1 mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
63,112451,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]|niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
64,112452,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,664714,CYP1A5,https://ctdbase.org/detail.go?type=gene&acc=664714,,,664714,,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A5 mrna]|niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A5 protein],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
65,112453,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,226143,CYP2C23,https://ctdbase.org/detail.go?type=gene&acc=226143,,,226143,Cyp2c23,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP2C23 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
66,112688,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased activity of CYP2E1 protein]|[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP2E1 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
67,112689,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682,Cyp3a2,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP3A2 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
68,112690,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1673,DEFB4A,https://ctdbase.org/detail.go?type=gene&acc=1673,,,1673,DEFB4A,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DEFB4A mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
69,112691,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23405,DICER1,https://ctdbase.org/detail.go?type=gene&acc=23405,,,23405,DICER1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DICER1 mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
70,112692,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739,DLG1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DLG1 mrna|niacinamide inhibits the reaction [geranylgeranylacetone results in increased expression of DLG1 mrna],,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
71,112693,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786,DNMT1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mrna]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
72,112694,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978,EIF4EBP1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of EIF4EBP1 protein]|niacinamide results in increased phosphorylation of EIF4EBP1 protein,,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
73,112695,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978,EIF4EBP1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of EIF4EBP1 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
74,112696,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033,EP300,9606,Homo sapiens (human),Niacinamide results in increased expression of and results in increased acetylation of EP300 protein,,,PMID:23297412,https://www.ncbi.nlm.nih.gov/pubmed/23297412,23297412,,
75,113021,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2074,ERCC6,https://ctdbase.org/detail.go?type=gene&acc=2074,,,2074,ERCC6,9606,Homo sapiens (human),"ERCC6 gene mutant form results in increased abundance of niacinamide|ercc6 gene mutant form promotes the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased abundance of niacinamide]",,,PMID:25440059,https://www.ncbi.nlm.nih.gov/pubmed/25440059,25440059,,
76,113022,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152,F3,9606,Homo sapiens (human),Niacinamide results in decreased expression of F3 protein,,,PMID:14627904,https://www.ncbi.nlm.nih.gov/pubmed/14627904,14627904,,
77,113023,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103,Fasl,10090,Mus musculus (house mouse),CD38 gene mutant form promotes the reaction [niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of naadp]]]|niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]],,,PMID:20200208,https://www.ncbi.nlm.nih.gov/pubmed/20200208,20200208,,
78,113024,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353,FOS,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of FOS protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
79,113025,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9606,Homo sapiens (human),Niacinamide results in increased expression of and results in increased acetylation of FOXO1 protein|[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of FOXO1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
80,113026,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mrna]|niacinamide inhibits the reaction [FOXO1 protein results in increased expression of G6PC1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
81,113027,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [FOXO1 protein binds to SIRT1 protein]|niacinamide inhibits the reaction [dexamethasone results in decreased acetylation of FOXO1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
82,113028,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9823,Sus scrofa (pig),Niacinamide results in increased expression of FOXO1 mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
83,113029,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3931,LCAT,https://ctdbase.org/detail.go?type=gene&acc=3931,,,3931,LCAT,10116,Rattus norvegicus (Norway rat),Tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein]|[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein|chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein]|[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein],,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
84,113227,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972,LHB,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased secretion of LHB protein],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
85,113228,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3772547,LNCRNA:HSROMEGA,https://ctdbase.org/detail.go?type=gene&acc=3772547,,,3772547,lncRNA:Hsromega,7227,Drosophila melanogaster (fruit fly),Niacinamide results in increased expression of LNCRNA:HSROMEGA mRNA,,,PMID:9364937,https://www.ncbi.nlm.nih.gov/pubmed/9364937,9364937,,
86,113229,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,9606,Homo sapiens (human),Niacinamide results in increased acetylation of PPARGC1A protein,,,PMID:19071085,https://www.ncbi.nlm.nih.gov/pubmed/19071085,19071085,,
87,113230,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023,LPL,10116,Rattus norvegicus (Norway rat),Chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein]|[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein]|tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein]|[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein,,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
88,113231,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,389692,MAFA,https://ctdbase.org/detail.go?type=gene&acc=389692,,,389692,MAFA,9606,Homo sapiens (human),Niacinamide inhibits the reaction [glucose inhibits the reaction [MAFA protein binds to INS promoter]],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
89,113232,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631,MAP1LC3B,9606,Homo sapiens (human),Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
90,113233,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased phosphorylation of MAPK8 protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
91,113234,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193,MDM2,9606,Homo sapiens (human),Niacinamide results in increased expression of MDM2 mRNA,,,PMID:16998810,https://www.ncbi.nlm.nih.gov/pubmed/16998810,16998810,,
92,113235,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,102466056,MIR125B,https://ctdbase.org/detail.go?type=gene&acc=102466056,,,102466056,,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of MIR125B]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of mir125b]|[streptozocin co-treated with niacinamide] results in increased expression of MIR125B",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
93,113433,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,406983,MIR200A,https://ctdbase.org/detail.go?type=gene&acc=406983,,,406983,MIR200A,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of mir200a]|metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of mir200a]|[streptozocin co-treated with niacinamide] results in increased expression of MIR200A",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
94,113434,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,387199,MIR203,https://ctdbase.org/detail.go?type=gene&acc=387199,,,387199,Mir203,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene affects the expression of MIR203 mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
95,113435,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
96,113436,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Niacinamide results in increased expression of MMP9 protein|resveratrol inhibits the reaction [niacinamide results in increased expression of MMP9 protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
97,113437,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4482,MSRA,https://ctdbase.org/detail.go?type=gene&acc=4482,,,4482,MSRA,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased expression of MSRA protein],,,PMID:23022493,https://www.ncbi.nlm.nih.gov/pubmed/23022493,23022493,,
98,113438,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475,MTOR,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein]|niacinamide results in increased phosphorylation of MTOR protein,,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
99,113439,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609,MYC,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MYC mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MYC protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
100,113440,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609,MYC,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [butylhydroxybutylnitrosamine results in increased expression of and results in increased localization of MYC protein],,,PMID:22028816,https://www.ncbi.nlm.nih.gov/pubmed/22028816,22028816,,
101,113441,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,79035,NABP2,https://ctdbase.org/detail.go?type=gene&acc=79035,,,79035,NABP2,9606,Homo sapiens (human),Trichostatin A promotes the reaction [niacinamide results in decreased ubiquitination of NABP2 protein]|niacinamide results in increased acetylation of NABP2 protein|trichostatin A promotes the reaction [niacinamide results in increased acetylation of NABP2 protein]|niacinamide results in decreased ubiquitination of NABP2 protein|niacinamide promotes the reaction [trichostatin A results in decreased ubiquitination of NABP2 protein]|niacinamide promotes the reaction [trichostatin A results in increased acetylation of NABP2 protein],,,PMID:26170237,https://www.ncbi.nlm.nih.gov/pubmed/26170237,26170237,,
102,113667,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135,NAMPT,9606,Homo sapiens (human),Niacinamide results in decreased expression of NAMPT protein|[berberine co-treated with niacinamide] results in decreased expression of NAMPT protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
103,113668,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135,NAMPT,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased expression of NAMPT mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
104,113669,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611,NCOR1,10090,Mus musculus (house mouse),Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein]|niacinamide results in decreased expression of NCOR1 protein,,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
105,113670,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4694,NDUFA1,https://ctdbase.org/detail.go?type=gene&acc=4694,,,4694,NDUFA1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA1 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
106,113671,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,51079,NDUFA13,https://ctdbase.org/detail.go?type=gene&acc=51079,,,51079,NDUFA13,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA13 protein]|niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA13 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
107,113672,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4695,NDUFA2,https://ctdbase.org/detail.go?type=gene&acc=4695,,,4695,NDUFA2,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA2 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
108,113673,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,10090,Mus musculus (house mouse),"Metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein]|[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
109,113674,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [SIRT1 protein results in increased expression of PPARGC1A mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
110,113675,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein,,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
111,113676,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
112,113869,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790,NFKB1,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of NFKB1 mrna],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
113,113870,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [resveratrol results in decreased expression of NOS2 mrna]|niacinamide inhibits the reaction [resveratrol results in decreased expression of NOS2 protein],,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
114,113871,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,100169685,NOX2,https://ctdbase.org/detail.go?type=gene&acc=100169685,,,100169685,,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
115,113872,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507,NOX4,10116,Rattus norvegicus (Norway rat),GW 6471 inhibits the reaction [resveratrol inhibits the reaction [niacinamide results in increased expression of NOX4 mrna]]|resveratrol inhibits the reaction [niacinamide results in increased expression of NOX4 mrna]|niacinamide results in increased expression of NOX4 mRNA,,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
116,113873,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna]|metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
117,113874,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164,NR4A1,10090,Mus musculus (house mouse),[glycerol co-treated with succinic acid co-treated with glucose-6-phosphate co-treated with pantothenic acid co-treated with niacinamide] results in increased expression of NR4A1 mRNA,,,PMID:20505214,https://www.ncbi.nlm.nih.gov/pubmed/20505214,20505214,,
118,113875,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967,OGDH,9606,Homo sapiens (human),Niacinamide inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased activity of OGDH protein],,,PMID:18381761,https://www.ncbi.nlm.nih.gov/pubmed/18381761,18381761,,
119,113876,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of PARP1 protein|niacinamide results in increased cleavage of PARP1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
120,113877,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [sodium arsenite results in decreased expression of PARP1 protein],,,PMID:36958258,https://www.ncbi.nlm.nih.gov/pubmed/36958258,36958258,,
121,114072,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in increased expression of PARP1 mrna|niacinamide results in increased expression of PARP1 protein,,,PMID:29143419,https://www.ncbi.nlm.nih.gov/pubmed/29143419,29143419,,
122,114073,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased activity of PARP1 protein|niacinamide inhibits the reaction [excitatory amino acid agonists results in increased activity of PARP1 protein]|niacinamide inhibits the reaction [excitatory amino acid agonists results in decreased expression of PARP1 protein],,,PMID:19288225,https://www.ncbi.nlm.nih.gov/pubmed/19288225,19288225,,
123,114074,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased activity of PARP1 protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
124,114075,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased cleavage of PARP1 protein],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
125,114076,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in decreased activity of PARP1 protein,,,PMID:7590113|PMID:8742498,https://www.ncbi.nlm.nih.gov/pubmed/7590113|https://www.ncbi.nlm.nih.gov/pubmed/8742498,7590113|8742498,,
126,114077,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the chemical synthesis of niacinamide,,,PMID:16026317,https://www.ncbi.nlm.nih.gov/pubmed/16026317,16026317,,
127,114078,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166,PDK4,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [dexamethasone results in increased expression of PDK4 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
128,114079,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,54704,PDP1,https://ctdbase.org/detail.go?type=gene&acc=54704,,,54704,PDP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [dexamethasone results in increased phosphorylation of PDP1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
129,114080,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308,PITX2,9606,Homo sapiens (human),Niacinamide results in increased expression of PITX2 protein|niacinamide results in increased expression of PITX2 mRNA,,,PMID:29143419,https://www.ncbi.nlm.nih.gov/pubmed/29143419,29143419,,
130,114081,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376,PMP22,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein],,,PMID:22028816,https://www.ncbi.nlm.nih.gov/pubmed/22028816,22028816,,
131,114289,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9615,Canis lupus familiaris (dog),Niacinamide results in increased expression of PPARG protein|resveratrol inhibits the reaction [niacinamide results in increased expression of PPARG protein]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|niacinamide affects the reaction [PPARG protein binds to NCOR1 protein]|[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [niacinamide results in increased expression of PPARG],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
132,114290,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of PPARG protein|quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of PPARG protein]|eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of PPARG protein],,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
133,114291,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9823,Sus scrofa (pig),Niacinamide results in increased expression of PPARG mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
134,114292,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased acetylation of and results in decreased expression of PPARGC1A protein]|niacinamide results in increased stability of PPARGC1A protein,,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
135,114293,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5562,PRKAA1,https://ctdbase.org/detail.go?type=gene&acc=5562,,,5562,PRKAA1,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of PRKAA1 protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
136,114294,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563,PRKAA2,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of PRKAA2 protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
137,114295,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
138,114296,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Resveratrol inhibits the reaction [niacinamide results in increased expression of PTGS2 protein]|niacinamide results in increased expression of PTGS2 protein,,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
139,114297,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836,PYGL,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of PYGL protein]|[streptozocin co-treated with niacinamide] affects the activity of PYGL protein,,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
140,114546,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,9606,Homo sapiens (human),Niacinamide results in increased acetylation of and results in increased phosphorylation of RELA protein|resveratrol inhibits the reaction [niacinamide results in increased phosphorylation of and results in increased acetylation of RELA protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
141,114547,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein]|[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
142,114548,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [resveratrol results in decreased expression of RELA protein modified form],,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
143,114549,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased acetylation of RELA protein],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
144,114550,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of RELA protein]|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of RELA protein]|[niacinamide co-treated with streptozocin] results in increased expression of RELA protein,,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
145,114551,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of RELA protein]|[streptozocin co-treated with niacinamide] results in increased expression of RELA protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of RELA protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
146,114552,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [AICA ribonucleotide inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [metformin inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
147,114553,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased activity of RELA protein]|[streptozocin co-treated with niacinamide] results in increased activity of RELA protein,,,PMID:23406761,https://www.ncbi.nlm.nih.gov/pubmed/23406761,23406761,,
148,114807,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194,RPS6,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of RPS6 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
149,114808,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198,RPS6KB1,9606,Homo sapiens (human),Niacinamide results in increased acetylation of RPS6KB1 protein,,,PMID:23248098,https://www.ncbi.nlm.nih.gov/pubmed/23248098,23248098,,
150,114809,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860,RUNX2,9615,Canis lupus familiaris (dog),Resveratrol inhibits the reaction [niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]|niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]|resveratrol inhibits the reaction [niacinamide results in increased acetylation of RUNX2 protein]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|resveratrol inhibits the reaction [niacinamide results in decreased expression of RUNX2 protein]|niacinamide results in decreased expression of RUNX2 protein|niacinamide results in increased acetylation of RUNX2 protein|[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [niacinamide results in increased expression of PPARG],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
151,114810,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860,RUNX2,10090,Mus musculus (house mouse),Niacinamide results in increased expression of RUNX2 mrna|niacinamide results in decreased expression of RUNX2 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
152,114811,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464,SHC1,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of SHC1 protein],,,PMID:24557422,https://www.ncbi.nlm.nih.gov/pubmed/24557422,24557422,,
153,114812,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464,SHC1,9606,Homo sapiens (human),Niacinamide results in increased expression of SHC1 mrna|niacinamide results in increased expression of SHC1 protein,,,PMID:21778425,https://www.ncbi.nlm.nih.gov/pubmed/21778425,21778425,,
154,114813,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9615,Canis lupus familiaris (dog),Resveratrol inhibits the reaction [niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]|niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|niacinamide results in decreased expression of SIRT1 protein|resveratrol inhibits the reaction [niacinamide results in decreased expression of SIRT1 protein],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
155,114814,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
156,114815,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [1,5-dihydroxyisoquinoline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased activity of SIRT1 protein]]",,,PMID:25517228,https://www.ncbi.nlm.nih.gov/pubmed/25517228,25517228,,
157,115101,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [icariin inhibits the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of SIRT1 protein]],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
158,115102,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased expression of SIRT1 protein|niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 protein],,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
159,115103,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen deficiency co-treated with oxygen] results in decreased expression of SIRT1 protein]|niacinamide inhibits the reaction [salvin inhibits the reaction [[oxygen deficiency co-treated with oxygen] results in decreased expression of SIRT1 protein]],,,PMID:24557422,https://www.ncbi.nlm.nih.gov/pubmed/24557422,24557422,,
160,115104,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:17103016|PMID:19071085|PMID:19664641|PMID:20169165|PMID:21745208|PMID:21892612|PMID:22385246|PMID:22990594,https://www.ncbi.nlm.nih.gov/pubmed/17103016|https://www.ncbi.nlm.nih.gov/pubmed/19071085|https://www.ncbi.nlm.nih.gov/pubmed/19664641|https://www.ncbi.nlm.nih.gov/pubmed/20169165|https://www.ncbi.nlm.nih.gov/pubmed/21745208|https://www.ncbi.nlm.nih.gov/pubmed/21892612|https://www.ncbi.nlm.nih.gov/pubmed/22385246|https://www.ncbi.nlm.nih.gov/pubmed/22990594,17103016|19071085|19664641|20169165|21745208|21892612|22385246|22990594,,
161,115105,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased susceptibility to hydrogen peroxide|[niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [hydrogen peroxide results in increased acetylation of TP53 protein],,,PMID:18681908,https://www.ncbi.nlm.nih.gov/pubmed/18681908,18681908,,
162,115106,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein],,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
163,115107,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of CXCL8 mrna|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DEFB4A mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
164,115108,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of EIF4EBP1 protein|[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of RPS6 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
165,115109,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased expression of SIRT1 mRNA,,,PMID:21745208,https://www.ncbi.nlm.nih.gov/pubmed/21745208,21745208,,
166,115305,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,40674,Mammalia (mammals),Niacinamide inhibits the reaction [SIRT1 protein results in increased activity of FOXO4 protein],,,PMID:16012755,https://www.ncbi.nlm.nih.gov/pubmed/16012755,16012755,,
167,115306,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mrna],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736,,
168,115307,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:16366736|PMID:34216621,https://www.ncbi.nlm.nih.gov/pubmed/16366736|https://www.ncbi.nlm.nih.gov/pubmed/34216621,16366736|34216621,,
169,115308,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [SIRT1 protein results in increased expression of PPARGC1A mrna]|niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 mrna]|niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 protein],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
170,115309,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DLG1 mRNA,,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
171,115310,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to resveratrol,,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
172,115311,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with resveratrol] promotes the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of SIRT1 mrna]|[resveratrol co-treated with niacinamide] promotes the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of SIRT1 protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
173,115312,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [excitatory amino acid agonists results in decreased expression of and results in decreased activity of SIRT1 protein]|niacinamide inhibits the reaction [SIRT1 protein results in decreased abundance of NAD],,,PMID:19288225,https://www.ncbi.nlm.nih.gov/pubmed/19288225,19288225,,
174,115313,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
175,115510,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol promotes the reaction [pilocarpine results in increased expression of SIRT1 protein]],,,PMID:23211629,https://www.ncbi.nlm.nih.gov/pubmed/23211629,23211629,,
176,115511,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:16366736|PMID:19288225|PMID:23479127|PMID:28973641,https://www.ncbi.nlm.nih.gov/pubmed/16366736|https://www.ncbi.nlm.nih.gov/pubmed/19288225|https://www.ncbi.nlm.nih.gov/pubmed/23479127|https://www.ncbi.nlm.nih.gov/pubmed/28973641,16366736|19288225|23479127|28973641,,
177,115512,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of cholesterol]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of glucose]|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to fructose|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of ACACA mrna]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of HMGCR mrna],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
178,115513,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in decreased expression of AGTR1 mrna]|[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of AGTR1 mRNA,,,PMID:18420994,https://www.ncbi.nlm.nih.gov/pubmed/18420994,18420994,,
179,115514,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042,TGFB2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mrna]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
180,115515,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to metformin|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to salicylic acid|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to resveratrol|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to AICA ribonucleotide,,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
181,115516,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein,,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
182,115517,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased expression of SIRT1 protein,,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
183,115712,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9823,Sus scrofa (pig),Niacinamide results in decreased expression of SIRT1 mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
184,115713,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide binds to and results in decreased activity of SIRT1 protein,,,PMID:18849969,https://www.ncbi.nlm.nih.gov/pubmed/18849969,18849969,,
185,115714,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide co-treated with trichostatin A] inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:15788402,https://www.ncbi.nlm.nih.gov/pubmed/15788402,15788402,,
186,115715,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:17452443|PMID:18420994|PMID:18681908|PMID:19303434|PMID:19720090|PMID:20181797|PMID:20429690|PMID:21212096|PMID:21232033|PMID:23022493|PMID:23422569|PMID:23735732|PMID:23770283|PMID:23891692|PMID:24894820|PMID:24962570|PMID:25108154|PMID:26420067,https://www.ncbi.nlm.nih.gov/pubmed/17452443|https://www.ncbi.nlm.nih.gov/pubmed/18420994|https://www.ncbi.nlm.nih.gov/pubmed/18681908|https://www.ncbi.nlm.nih.gov/pubmed/19303434|https://www.ncbi.nlm.nih.gov/pubmed/19720090|https://www.ncbi.nlm.nih.gov/pubmed/20181797|https://www.ncbi.nlm.nih.gov/pubmed/20429690|https://www.ncbi.nlm.nih.gov/pubmed/21212096|https://www.ncbi.nlm.nih.gov/pubmed/21232033|https://www.ncbi.nlm.nih.gov/pubmed/23022493|https://www.ncbi.nlm.nih.gov/pubmed/23422569|https://www.ncbi.nlm.nih.gov/pubmed/23735732|https://www.ncbi.nlm.nih.gov/pubmed/23770283|https://www.ncbi.nlm.nih.gov/pubmed/23891692|https://www.ncbi.nlm.nih.gov/pubmed/24894820|https://www.ncbi.nlm.nih.gov/pubmed/24962570|https://www.ncbi.nlm.nih.gov/pubmed/25108154|https://www.ncbi.nlm.nih.gov/pubmed/26420067,17452443|18420994|18681908|19303434|19720090|20181797|20429690|21212096|21232033|23022493|23422569|23735732|23770283|23891692|24894820|24962570|25108154|26420067,,
187,115716,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933,SIRT2,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT2 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
188,115717,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933,SIRT2,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT2 protein,,,PMID:17341628,https://www.ncbi.nlm.nih.gov/pubmed/17341628,17341628,,
189,115718,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410,SIRT3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
190,115719,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,51548,SIRT6,https://ctdbase.org/detail.go?type=gene&acc=51548,,,51548,SIRT6,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [beta-naphthoflavone results in decreased expression of and results in decreased activity of SIRT6 protein],,,PMID:28536482,https://www.ncbi.nlm.nih.gov/pubmed/28536482,28536482,,
191,115720,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517,SLC2A4,10116,Rattus norvegicus (Norway rat),Eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of SLC2A4 protein]|quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of SLC2A4 protein]|[streptozocin co-treated with niacinamide] results in decreased expression of SLC2A4 protein,,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
192,115919,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517,SLC2A4,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in decreased expression of SLC2A4 mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
193,115920,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,28250,SLCO1A4,https://ctdbase.org/detail.go?type=gene&acc=28250,,,28250,Slco1a4,10090,Mus musculus (house mouse),SLCO1A4 protein affects the abundance of niacinamide,,,PMID:21561886,https://www.ncbi.nlm.nih.gov/pubmed/21561886,21561886,,
194,115921,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8773,SNAP23,https://ctdbase.org/detail.go?type=gene&acc=8773,,,8773,SNAP23,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of SNAP23 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of SNAP23 mRNA,,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
195,115922,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein]|[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
196,115923,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,10116,Rattus norvegicus (Norway rat),Dronabinol promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of SOD1 protein]|[streptozocin co-treated with niacinamide] results in increased expression of SOD1 protein,,,PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/31081965,31081965,,
197,115924,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648,SOD2,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of SOD2 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
198,115925,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648,SOD2,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of SOD2 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
199,115926,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662,SOX9,9606,Homo sapiens (human),"Resveratrol inhibits the reaction [niacinamide results in decreased expression of SOX9 protein]|4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [niacinamide results in decreased expression of SOX9 protein]|niacinamide results in decreased expression of SOX9 protein",,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
200,115927,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878,SQSTM1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [sirolimus results in decreased expression of SQSTM1 protein],,,PMID:24238063,https://www.ncbi.nlm.nih.gov/pubmed/24238063,24238063,,
201,116124,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720,SREBF1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [platycodin D inhibits the reaction [glucose results in increased expression of SREBF1 protein]],,,PMID:23319015,https://www.ncbi.nlm.nih.gov/pubmed/23319015,23319015,,
202,116125,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6810,STX4,https://ctdbase.org/detail.go?type=gene&acc=6810,,,6810,STX4,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of STX4 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of STX4 mRNA,,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
203,116126,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015,TERT,10029,Cricetulus griseus (Chinese hamster),Niacinamide results in decreased activity of TERT protein,,,PMID:11563329,https://www.ncbi.nlm.nih.gov/pubmed/11563329,11563329,,
204,116127,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040,TGFB1,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mrna|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein]|[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
205,116128,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,25976,TIPARP,https://ctdbase.org/detail.go?type=gene&acc=25976,,,25976,TIPARP,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of TIPARP mrna],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
206,116129,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]|niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
207,116130,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Niacinamide results in increased expression of TNF mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
208,116131,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein]|[streptozocin co-treated with niacinamide] results in increased expression of TNF protein|[streptozocin co-treated with niacinamide] results in increased expression of TNF mrna|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF mrna]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
209,116327,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased expression of CD40 mrna]|niacinamide promotes the reaction [TNF protein results in increased acetylation of RELA protein],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
210,116328,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of TNF protein]|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of TNF protein]|[niacinamide co-treated with streptozocin] results in increased expression of TNF protein,,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
211,116329,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
212,116330,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of TNF protein,,,PMID:21439372|PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/31081965,21439372|31081965,,
213,116331,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982,TNFRSF11B,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of TNFRSF11B mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
214,116332,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600,TNFSF11,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of TNFSF11 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
215,116333,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide results in increased phosphorylation of and results in increased acetylation of TP53 protein|[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of TP53 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
216,116334,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide results in decreased expression of TP53 protein|niacinamide inhibits the reaction [tert-butylhydroperoxide results in increased expression of TP53 protein],,,PMID:12782109,https://www.ncbi.nlm.nih.gov/pubmed/12782109,12782109,,
217,116335,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [hydrogen peroxide results in increased acetylation of TP53 protein],,,PMID:18681908,https://www.ncbi.nlm.nih.gov/pubmed/18681908,18681908,,
218,116539,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein],,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
219,116540,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059,Trp53,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
220,116541,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299,TYR,9606,Homo sapiens (human),Niacinamide results in increased expression of TYR mrna|niacinamide results in increased expression of TYR protein,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
221,116542,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351,UCP2,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mrna],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736|16366736,,
222,116543,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6844,VAMP2,https://ctdbase.org/detail.go?type=gene&acc=6844,,,6844,VAMP2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of VAMP2 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of VAMP2 mRNA,,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
223,116544,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607,Agtr1a,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
224,116545,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased phosphorylation of AKT1 protein|quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased phosphorylation of AKT1 protein]|eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased phosphorylation of AKT1 protein],,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
225,116546,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317,APAF1,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
226,116753,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Niacinamide results in increased expression of BAX protein|[berberine co-treated with niacinamide] results in increased expression of BAX protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
227,116754,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Niacinamide results in increased expression of BAX mRNA,,,PMID:16998810,https://www.ncbi.nlm.nih.gov/pubmed/16998810,16998810,,
228,116755,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX mrna]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
229,116756,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of BAX protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
230,116757,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased expression of BAX mrna]|niacinamide inhibits the reaction [thiotepa results in increased expression of BAX protein],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
231,116758,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113,BBC3,9606,Homo sapiens (human),Niacinamide results in increased expression of BBC3 mrna|[berberine co-treated with niacinamide] results in increased expression of BBC3 mRNA,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
232,116759,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of BCL2 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
233,116760,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of BCL2 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
234,116761,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
235,116960,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018,BCL2L11,9606,Homo sapiens (human),Niacinamide results in increased expression of BCL2L11 mrna|[berberine co-treated with niacinamide] results in increased expression of BCL2L11 mRNA,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
236,116961,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018,BCL2L11,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in increased expression of BCL2L11 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
237,116962,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,648,BMI1,https://ctdbase.org/detail.go?type=gene&acc=648,,,648,BMI1,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BMI1 mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
238,116963,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of CASP3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
239,116964,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Niacinamide results in increased cleavage of CASP3 protein,,,PMID:24962570|PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/24962570|https://www.ncbi.nlm.nih.gov/pubmed/26712469,24962570|26712469,,
240,116965,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Resveratrol inhibits the reaction [niacinamide results in increased cleavage of CASP3 protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
241,116966,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
242,116967,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [hydrogen peroxide results in increased cleavage of CASP3 protein]|niacinamide promotes the reaction [antimycin A results in increased cleavage of CASP3 protein],,,PMID:24040102,https://www.ncbi.nlm.nih.gov/pubmed/24040102,24040102,,
243,116968,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [hydrogen peroxide results in increased cleavage of CASP3 protein],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
244,117232,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased activity of CASP3 protein],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
245,117233,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of CASP9 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
246,117234,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147,CHUK,9606,Homo sapiens (human),Resveratrol inhibits the reaction [niacinamide results in increased activity of CHUK protein]|niacinamide results in increased activity of CHUK protein,,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
247,117235,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
248,117236,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mrna]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
249,117237,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [hydrogen peroxide results in increased cleavage of CASP9 protein],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
250,117238,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]|[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
251,117239,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9606,Homo sapiens (human),Niacinamide results in increased acetylation of FOXO1 protein|niacinamide inhibits the reaction [hydrogen peroxide results in increased localization of FOXO1 protein]|niacinamide inhibits the reaction [resveratrol results in increased localization of FOXO1 protein]|[niacinamide co-treated with trichostatin A] inhibits the reaction [FOXO1 protein binds to SIRT1 protein]|niacinamide affects the localization of FOXO1 protein,,,PMID:15788402,https://www.ncbi.nlm.nih.gov/pubmed/15788402,15788402,,
252,117446,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of FOXO3 protein|niacinamide results in increased expression of and results in increased acetylation of FOXO3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
253,117447,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in increased acetylation of FOXO3 protein]|niacinamide inhibits the reaction [icariin inhibits the reaction [[oxygen co-treated with oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
254,117448,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased expression of FOXO3 protein],,,PMID:23022493,https://www.ncbi.nlm.nih.gov/pubmed/23022493,23022493,,
255,117449,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4303,FOXO4,https://ctdbase.org/detail.go?type=gene&acc=4303,,,4303,FOXO4,40674,Mammalia (mammals),Niacinamide inhibits the reaction [SIRT1 protein results in increased activity of FOXO4 protein]|niacinamide results in decreased activity of FOXO4 protein,,,PMID:16012755,https://www.ncbi.nlm.nih.gov/pubmed/16012755,16012755,,
256,117450,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495,FTH1,9606,Homo sapiens (human),Niacinamide results in increased expression of FTH1 protein|niacinamide results in increased expression of FTH1 mRNA,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
257,117451,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538,G6PC1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of G6PC1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
258,117452,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539,G6PD,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of G6PD protein]|[streptozocin co-treated with niacinamide] affects the activity of G6PD protein,,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
259,117453,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641,GCG,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of GCG mrna|sitagliptin phosphate inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCG mrna],,,PMID:23466488,https://www.ncbi.nlm.nih.gov/pubmed/23466488,23466488,,
260,117454,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729,GCLC,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
261,117789,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720,GLB1,10116,Rattus norvegicus (Norway rat),Niacinamide results in increased expression of GLB1 protein|niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of GLB1 protein]],,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
262,117790,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739,GLO1,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein]|[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
263,117791,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of GPT protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
264,117792,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein]|[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
265,117793,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein]|[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
266,117794,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with resveratrol] inhibits the reaction [[ethanol co-treated with aflatoxin B1] results in decreased expression of GSR protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
267,117795,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947,GSTM3,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
268,117796,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950,GSTP1,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with resveratrol] inhibits the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of GSTP1 protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
269,117797,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2998,GYS2,https://ctdbase.org/detail.go?type=gene&acc=2998,,,2998,GYS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of GYS2 protein]|[streptozocin co-treated with niacinamide] affects the activity of GYS2 protein,,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
270,117987,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3039,HBA1,https://ctdbase.org/detail.go?type=gene&acc=3039,,,3039,HBA1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased glycosylation of HBA1 protein|coumarin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased glycosylation of HBA1 protein],,,PMID:19647726,https://www.ncbi.nlm.nih.gov/pubmed/19647726,19647726,,
271,117988,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065,HDAC1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
272,117989,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10116,Rattus norvegicus (Norway rat),[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein]|[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein|chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein]|tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein],,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
273,117990,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of HMGCR mrna],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
274,117991,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein]|[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
275,117992,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
276,117993,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,9606,Homo sapiens (human),[niacinamide co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IFNG mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
277,117994,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,9606,Homo sapiens (human),Niacinamide promotes the reaction [tetradecanoylphorbol acetate results in increased expression of IFNG mrna],,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
278,117995,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484,IGFBP1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
279,118192,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586,IL10,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein|[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
280,118193,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide co-treated with ENV-2 compound] results in decreased expression of IL18 mRNA,,,PMID:28322830,https://www.ncbi.nlm.nih.gov/pubmed/28322830,28322830,,
281,118194,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Niacinamide results in decreased expression of IL1B mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
282,118195,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Niacinamide results in increased expression of IL1B mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
283,118196,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein]|[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
284,118197,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein]|[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein,,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
285,118198,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide co-treated with ENV-2 compound] results in decreased expression of IL1B mRNA,,,PMID:28322830,https://www.ncbi.nlm.nih.gov/pubmed/28322830,28322830,,
286,118199,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL1B mrna]",,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
287,118200,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558,IL2,9606,Homo sapiens (human),[niacinamide co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IL2 mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
288,118397,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558,IL2,9606,Homo sapiens (human),Niacinamide promotes the reaction [tetradecanoylphorbol acetate results in increased expression of IL2 mrna],,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
289,118398,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Niacinamide results in decreased expression of IL6 protein,,,PMID:12727023,https://www.ncbi.nlm.nih.gov/pubmed/12727023,12727023,,
290,118399,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein]|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein]|[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein,,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
291,118400,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
292,118401,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630,INS,9606,Homo sapiens (human),Niacinamide inhibits the reaction [glucose results in increased expression of INS mrna]|niacinamide inhibits the reaction [glucose results in increased expression of INS protein]|niacinamide inhibits the reaction [glucose inhibits the reaction [MAFA protein binds to INS promoter]],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
293,118402,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Coumarin inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased expression of INS1 protein]|[niacinamide co-treated with streptozocin] results in decreased expression of INS1 protein,,,PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/21630391,21630391,,
294,118403,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Coumarin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein],,,PMID:19647726,https://www.ncbi.nlm.nih.gov/pubmed/19647726,19647726,,
295,118404,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein]|quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein],,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
296,118405,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [glucose results in increased expression of INS1 protein],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736,,
297,118604,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein],,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
298,118605,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein,,,PMID:21382363|PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/21382363|https://www.ncbi.nlm.nih.gov/pubmed/25999625,21382363|25999625,,
299,118606,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein]|[streptozocin co-treated with niacinamide] results in decreased secretion of INS1 protein|thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased secretion of INS1 protein],,,PMID:21382363,https://www.ncbi.nlm.nih.gov/pubmed/21382363,21382363,,
300,118607,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein,,,PMID:19647726|PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/19647726|https://www.ncbi.nlm.nih.gov/pubmed/37566541,19647726|37566541,,
301,118608,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643,INSR,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INSR protein]|eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INSR protein]|[streptozocin co-treated with niacinamide] results in decreased expression of INSR protein,,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
302,118609,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8660,IRS2,https://ctdbase.org/detail.go?type=gene&acc=8660,,,8660,IRS2,10116,Rattus norvegicus (Norway rat),Eupafolin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IRS2 protein]|[streptozocin co-treated with niacinamide] results in decreased expression of IRS2 protein|quercetin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IRS2 protein],,,PMID:37566541,https://www.ncbi.nlm.nih.gov/pubmed/37566541,37566541,,
303,118610,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of JUN protein]|niacinamide inhibits the reaction [methylnitrosourea results in increased phosphorylation of JUN protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
304,118611,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3741,KCNA5,https://ctdbase.org/detail.go?type=gene&acc=3741,,,3741,KCNA5,9606,Homo sapiens (human),Niacinamide affects the reaction [geranylgeranylacetone results in increased expression of KCNA5 protein],,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
305,118612,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817,KEAP1,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna]|metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
306,118817,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817,KEAP1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mrna]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mrna|[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
307,118818,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314,KLF4,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] promotes the reaction [dronabinol results in increased expression of KLF4 mrna],,,PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/31081965,31081965,,
308,141785,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),50119.0,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,
309,141786,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,233,Poly [ADP-ribose] polymerase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=233,O88554,Poly [ADP-ribose] polymerase 2,11546,Parp2,10090,Mus musculus (house mouse),,IC50 (nM),208930.0,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,
